The First Crispr Treatment Is Making Its Way to Patients
It’s been a year since the gene-editing treatment Casgevy was approved for sickle cell disease and a related blood disorder.
Hosted on MSN2h
Importance of genetic testing in the IVF procedure
Hence genetic testing is important and it is imperative to test ... There are 3 different modalities of PGT: PGT-A (Aneuploidies), PGT-M (Monogenic disorders) like Beta thalassemia, cystic fibrosis, ...
Structural analysis shows Alzheimer's disease mutation produces 'cottonwool' structures in the brain
An international collaboration led by RIKEN researchers has discovered how unusual spherical structures form in the brains of ...
bluebird bio Reports Third Quarter 2024 Results and Highlights Operational Progress and 2024 Guidance
SOMERVILLE, Mass.--(BUSINESS WIRE)--bluebird bio, Inc. (NASDAQ: BLUE) ("bluebird bio" or the "Company") today reported third quarter results and business highlights for the quarter ended September ...
manilatimes23h
Two New Solutions from Hemex Health Empower More Clinicians and Health Workers to Test for Iron Deficiency Anaemia and Sickle Cell Disease
A next generation Snap Cartridge, part of the Gazelle™ S-10B Hb Variant Test Multipack, will simplify sample preparation so ...
Yahoo Finance23h
Orsini Now Distributing CASGEVY® (exagamglogene autotemcel), a Gene-Editing Therapy
CASGEVY is a CRISPR/Cas9 gene-edited cell therapy indicated for the treatment of patients aged 12 years and older with (1) ...